Class IITerminated in FDA datasetRecall initiated Jun 10, 2025

Great Plains Bentonite + Herbal Detox Capsules 60 capsules, packaged in PETE amber bottle,…

Recalling firm: Yerba Prima Inc

Why it was recalled

Potential contamination with Pseudomonas aeruginosa.

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Sep 5, 2025.

Check your package

Compare the exact product and package details with the label you have.

ProductGreat Plains Bentonite + Herbal Detox Capsules 60 capsules, packaged in PETE amber bottle, white plastic cap and tamper proof seal. Case GTIN code:100 46352 00518 5. Retail package UPC code: 0 46352 00518 8. Yerba Prima, Inc. 740 Jefferson Ave Ashland, Oregon 97520 USA
UPC046352005188

FDA code information

Lot # 05051, Expiration Date 02/2028. Lot code breaks down as follows: 050 = 3 digits pertaining to the day of the year 5 = last number of the year 2025 1 = number of batch records issued of the day

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Great Plains Bentonite + Herbal Detox Capsules 60 capsules, packaged in PETE amber bottle, white plastic cap and tamper proof seal. Case GTIN code:100 46352 00518 5. Retail package UPC code: 0 46352 00518 8. Yerba Prima, Inc. 740 Jefferson Ave Ashland, Oregon 97520 USA

Extracted codes and context

TypeCode / valueContext
UPC046352005188 tamper proof seal. Case GTIN code:100 46352 00518 5. Retail package UPC code: 0 46352 00518 8. Yerba Prima, Inc. 740 Jefferson Ave Ashland, Oregon 97520 USA
lot05051Lot # 05051, Expiration Date 02/2028. Lot code breaks down as follows: 050 = 3 digits pertaining to the day of the year 5 = last

Original FDA recall reason

Potential contamination with Pseudomonas aeruginosa.

Recall details

Recall number
H-0050-2025
Event ID
97056
FDA status
Terminated
Initiated
Jun 10, 2025
Reported
Jun 25, 2025
Classified
Jun 17, 2025
Terminated
Sep 5, 2025
Quantity
4985 bottles
Location
Ashland, OR, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

Distributed in AZ, CA, CO, CT, FL, GA, IA, IL, IN, KY, MD, MO, NC, NH, NV, NY, OH, PA, TX, VA, and WA.

FDA source record · H-0050-2025

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.